Financial Toxicity in Cancer Patients
Financial Toxicity in Diverse Cancer Populations and Care Settings
2 other identifiers
observational
625
1 country
6
Brief Summary
This study will seek to generate the early data needed to understand the relationship between constructs and measures of patients' coping resources and psychological response and measures of patients' financial toxicity. To collect this early descriptive data, the overall goal of this study is to identify social, behavioral, and knowledge factors associated with financial toxicity outcomes. Identifying these factors will ultimately help elucidate targets for behavioral, psychosocial, and/or educational and coaching interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2020
CompletedFirst Submitted
Initial submission to the registry
October 12, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
April 16, 2026
April 1, 2026
8 years
October 12, 2020
April 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Financial toxicity score
Will be measured using the ENRICh instrument. Will conduct descriptive and univariate/multivariate analyses on this association of primary interest, including Chi-square test, t-test (or non-parametric test as appropriate). Other univariate associations between financial toxicity and other covariates obtained from survey measures, considered descriptive, will be performed. will test the primary association between the Hope State measure and financial toxicity using multivariate generalized linear mixed models, accounting for longitudinal changes in outcome scores over time, as well as adjusting for covariates and potential time interactions. The mixed effects structure will also be used, via a random intercept term, to account for site-to-site differences (e.g. clustering). Standard model selection procedures (forward, backward, or stepwise selection or shrinkage penalty) will be applied to determine the final multivariate model.
At 6 months
Study Arms (1)
Observational (survey)
Participants will complete a survey packet that is estimated to take about 30 minutes. The survey packet will be collected at baseline and at 6 months.
Interventions
Eligibility Criteria
Participants who have a diagnosis of cancer within the past 365 days
You may qualify if:
- Participant must be able to read and speak English or Spanish
- Participant must have diagnosis of cancer within the past 365 days; all disease sites and all stages are eligible for enrollment
You may not qualify if:
- Unable to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Institutes of Health (NIH)collaborator
Study Sites (6)
DCH Regional Medical Center
Tuscaloosa, Alabama, 35401, United States
Scripps - MD Anderson Cancer Center
La Jolla, California, 92037, United States
Baptist- MD Anderson Cancer Center
Jacksonville, Florida, 32207, United States
The Queen's Medical Center
Honolulu, Hawaii, 96813, United States
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026, United States
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grace Smith
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2020
First Posted
October 19, 2020
Study Start
September 12, 2020
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
April 16, 2026
Record last verified: 2026-04